[HTML][HTML] Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …

P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013 - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …

Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies

J Fraczek, J Bolleyn, T Vanhaecke, V Rogiers… - Archives of …, 2013 - Springer
Continuously increasing understanding of the molecular triggers responsible for the onset of
diseases, paralleled by an equally dynamic evolution of chemical synthesis and screening …

[HTML][HTML] New insight in HDACs: Potential therapeutic targets for the treatment of atherosclerosis

Y Luan, H Liu, Y Luan, Y Yang, J Yang… - Frontiers in …, 2022 - frontiersin.org
Atherosclerosis (AS) features include progressive hardening and reduced elasticity of
arteries. AS is the leading cause of morbidity and mortality. An increasing amount of …

Histone deacetylases (HDACs) as therapeutic target for depressive disorders

P Misztak, P Pańczyszyn-Trzewik… - Pharmacological …, 2018 - Elsevier
Major depressive disorder (MDD) represents approximately 40% of the disability caused by
mental illnesses globally. The poorly understood pathophysiology and limited efficiency of …

[HTML][HTML] Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental …

H Fredly, BT Gjertsen, Ø Bruserud - Clinical epigenetics, 2013 - Springer
Several new therapeutic strategies are now considered for acute myeloid leukemia (AML)
patients unfit for intensive chemotherapy, including modulation of protein lysine acetylation …

Histone deacetylases (HDAC) in physiological and pathological bone remodelling

MD Cantley, ACW Zannettino, PM Bartold, DP Fairlie… - Bone, 2017 - Elsevier
Histone deacetylases (HDACs) 2 play important roles in the epigenetic regulation of gene
expression in cells and are emerging therapeutic targets for treating a wide range of …

[HTML][HTML] A transcriptomics-based bioinformatics approach for identification and in vitro screening of FDA-approved drugs for repurposing against dengue virus-2

M Punekar, B Kasabe, P Patil, MB Kakade, D Parashar… - Viruses, 2022 - mdpi.com
The rising incidence of dengue virus (DENV) infections in the tropical and sub-tropical
regions of the world emphasizes the need to identify effective therapeutic drugs against the …

Peroxynitrite-modified histone as a pathophysiological biomarker in autoimmune diseases

MA Khan, K Alam, M Zafaryab, MMA Rizvi - Biochimie, 2017 - Elsevier
Under physiological conditions, reactive nitrogen and oxygen species are produced
continuously. However, excess of these radicals may damage biomolecules like lipids …

Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia

PT Shirazi, LN Eadie, SL Heatley, EC Page… - Cancer Gene …, 2022 - nature.com
TYK2-rearrangements have recently been identified in high-risk acute lymphoblastic
leukemia (HR-ALL) cases and are associated with poor outcome. Current understanding of …

Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia

PT Shirazi, LN Eadie, EC Page, SL Heatley, JB Bruning… - Cancer Letters, 2021 - Elsevier
Activating TYK2-rearrangements have recently been identified and implicated in the
leukemogenesis of high-risk acute lymphoblastic leukemia (HR-ALL) cases. Pre-clinical …